Margaret Kaczor
Stock Analyst at William Blair
(1.20)
# 3,452
Out of 4,732 analysts
28
Total ratings
43.75%
Success rate
-9.92%
Average return
Main Sectors:
Stocks Rated by Margaret Kaczor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Upgrades: Outperform | n/a | $17.62 | - | 3 | Jan 14, 2025 | |
| CBLL CeriBell | Initiates: Outperform | n/a | $21.04 | - | 1 | Nov 5, 2024 | |
| STIM Neuronetics | Downgrades: Market Perform | n/a | $2.46 | - | 4 | Aug 12, 2024 | |
| CUTR Cutera | Upgrades: Market Perform | n/a | $0.48 | - | 3 | Mar 22, 2024 | |
| INGN Inogen | Upgrades: Outperform | n/a | $10.47 | - | 5 | Feb 15, 2024 | |
| SKIN The Beauty Health Company | Downgrades: Market Perform | n/a | $1.74 | - | 2 | Nov 14, 2023 | |
| STAA STAAR Surgical Company | Downgrades: Market Perform | n/a | $22.29 | - | 1 | Jun 7, 2023 | |
| NVRO Nevro | Downgrades: Market Perform | n/a | $4.57 | - | 2 | Aug 5, 2021 | |
| DVA DaVita | Downgrades: Market Perform | n/a | $166.24 | - | 2 | Sep 11, 2019 | |
| MDT Medtronic | Assumes: Market Perform | n/a | $88.08 | - | 1 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $113.48 | - | 3 | Jan 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $84.38 | - | 1 | Apr 27, 2017 |
CVRx, Inc.
Jan 14, 2025
Upgrades: Outperform
Price Target: n/a
Current: $17.62
Upside: -
CeriBell
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $21.04
Upside: -
Neuronetics
Aug 12, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $2.46
Upside: -
Cutera
Mar 22, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $0.48
Upside: -
Inogen
Feb 15, 2024
Upgrades: Outperform
Price Target: n/a
Current: $10.47
Upside: -
The Beauty Health Company
Nov 14, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.74
Upside: -
STAAR Surgical Company
Jun 7, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $22.29
Upside: -
Nevro
Aug 5, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.57
Upside: -
DaVita
Sep 11, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $166.24
Upside: -
Medtronic
Jun 6, 2018
Assumes: Market Perform
Price Target: n/a
Current: $88.08
Upside: -
Jan 25, 2018
Upgrades: Outperform
Price Target: n/a
Current: $113.48
Upside: -
Apr 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $84.38
Upside: -